ANXA5 and B-cell chronic lymphocytic leukemia: In line with previous observations in CLL cell lines, CB-839 did not cause significant apoptosis in the cells, and the level of double-negative events as determined using annexin V/PI staining remained stable in all the treatment groups (P = 0.93).